ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

KROS Keros Therapeutics Inc

60.57
3.47 (6.08%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Keros Therapeutics Inc KROS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
3.47 6.08% 60.57 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
57.32 57.32 62.19 60.57 57.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/3/202407:00GLOBEKeros Therapeutics Announces U.S. FDA Fast Track Designation..
06/3/202407:01EDGAR2Form 8-K - Current report
05/3/202407:02EDGAR2Form 8-K - Current report
05/3/202407:01EDGAR2Form 8-K - Current report
05/3/202407:00GLOBEKeros Therapeutics to Present at Leerink Partners 2024..
28/2/202415:02EDGAR2Form 8-K - Current report
28/2/202415:01GLOBEKeros Therapeutics Reports Recent Business Highlights and..
23/2/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202407:00GLOBEKeros Therapeutics To Present at Pulmonary Vascular Research..
09/1/202407:01EDGAR2Form 8-K - Current report
09/1/202407:00GLOBEKeros Therapeutics Announces Closing of Upsized Public..
08/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:04EDGAR2Form 8-K - Current report
04/1/202415:04EDGAR2Form 144 - Report of proposed sale of securities
04/1/202415:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202420:29GLOBEKeros Therapeutics Announces Pricing of Upsized Public..
03/1/202415:05GLOBEKeros Therapeutics Announces Proposed Public Offering of..
03/1/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202407:04EDGAR2Form 8-K - Current report
11/12/202305:02EDGAR2Form 8-K - Current report
11/12/202305:00GLOBEKeros Therapeutics Presents Clinical Data from its KER-050..
07/11/202307:01EDGAR2Form 8-K - Current report
07/11/202307:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
06/11/202307:11EDGAR2Form 8-K - Current report
06/11/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202307:01EDGAR2Form 8-K - Current report
06/11/202307:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
02/11/202308:00GLOBEKeros Therapeutics to Present at the 65th American Society..
04/10/202307:01EDGAR2Form 8-K - Current report
04/10/202307:00GLOBEKeros Therapeutics Presents Preclinical Data from its..
05/9/202307:02EDGAR2Form 8-K - Current report
05/9/202307:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
07/8/202315:02EDGAR2Form 8-K - Current report
07/8/202307:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202307:00EDGAR2Form 8-K - Current report
07/8/202307:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
27/7/202315:01GLOBECorrected: Keros Therapeutics to Host Conference Call and..
24/7/202307:01EDGAR2Form 8-K - Current report
24/7/202307:00GLOBEKeros Therapeutics to Host Conference Call and Webcast to..
12/6/202307:00GLOBEKeros Therapeutics Announces Update to Participation at the..
09/6/202305:00GLOBEKeros Therapeutics Presents Clinical Trial and Preclinical..
07/6/202307:00GLOBEKeros Therapeutics to Present at Goldman Sach’s 44th Annual..
22/5/202308:00GLOBEKeros Therapeutics Presents Preclinical and Clinical Data..
11/5/202315:01GLOBEKeros Therapeutics to Present at the 28th Annual Congress of..

Su Consulta Reciente

Delayed Upgrade Clock